Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 7 lip 2018 · Noninvasive ventilation (NIV) has become the standard of care for respiratory support in patients with ALS. NIV use has demonstrated survival benefit and improved quality of life vs standard of care.

  2. Patients die, on average, within 3 to 5 years of diagnosis, unless they choose to undergo tracheostomy, in which case, they may live, on average, 2 additional years. Up to 95% of patients with ALS in the United States choose not to undergo tracheostomy; management of respiratory failure is therefore aimed at both prolonging survival as well as ...

  3. 3 lis 2016 · The first hospitalization for respiratory failure after the diagnosis of ALS was defined as the first hospitalization after the date of diagnosis with one of the following primary or any secondary ICD-9-CM codes: 518.81 acute respiratory failure, 518.83 chronic respiratory failure, 518.84 acute on chronic respiratory failure and 518.82 ...

  4. 8 maj 2020 · The aim of this paper is to review a patient’s disease history from diagnosis, through the occurrence of respiratory failure features, until the start of non-invasive ventilation (NIV), including the assessment of the efficacy of this therapy during respiratory failure exacerbation.

  5. 15 kwi 2015 · ALS leads to death in 15 to 20 months after diagnosis in 50 % of patients [2••], generally due to respiratory failure. An older age and bulbar involvement at onset are the main negative prognostic factors. Ten percent survives more than 10 years.

  6. PMID: 16723034. PMCID: PMC1550946. DOI: 10.1186/cc4926. Abstract. Introduction: Our objectives were to determine the causes of acute respiratory failure (ARF) in elderly patients and to assess the accuracy of the initial diagnosis by the emergency physician, and that of the prognosis.

  7. 15 kwi 2015 · Respiratory failure (RF) is a prevalent condition whose presence in elderly patients may be complex and require specific and specialized intervention. A multidimensional evaluation is necessary to choose the best treatment, taking into consideration functional capacity and frailty.